Effect of serum insulin on the association between hyperuricemia and incident heart failure.
Pubmed ID: 20920653
Pubmed Central ID: PMC2998195
Journal: The American journal of cardiology
Publication Date: Oct. 15, 2010
MeSH Terms: Humans, Male, Female, Aged, Risk Factors, United States, Heart Failure, Prognosis, Incidence, Hyperuricemia, Uric Acid, Hyperinsulinism, Insulin, Radioimmunoassay, Biomarkers
Grants: R01 HL085561, R01-HL085561, R01 HL097047, R01-HL097047
Authors: Ahmed MI, White M, Aronow WS, Ahmed A, Filippatos GS, Desai RV, Fonarow GC, Aban IB
Cite As: Desai RV, Ahmed MI, Fonarow GC, Filippatos GS, White M, Aban IB, Aronow WS, Ahmed A. Effect of serum insulin on the association between hyperuricemia and incident heart failure. Am J Cardiol 2010 Oct 15;106(8):1134-8.
Studies:
- Cardiovascular Health Study (CHS)
- Systolic Blood Pressure Intervention Trial (SPRINT)
- Systolic Blood Pressure Intervention Trial Primary Outcome Paper (SPRINT-POP) Data
Abstract
Increased serum uric acid (UA) is associated with incident heart failure (HF). However, whether it is a direct effect of UA or an effect of increased xanthine oxidase (XO) is unknown. Because hyperuricemia in hyperinsulinemia is primarily due to impaired renal UA excretion, its association with incident HF would suggest a direct UA effect. In contrast, hyperuricemia in normoinsulinemia is likely due to increased UA production and thus its association with incident HF would suggest an XO effect. To clarify this, we examined the association of hyperuricemia with centrally adjudicated incident HF in Cardiovascular Health Study participants with and without hyperinsulinemia. Of the 5,411 participants ≥ 65 years of age without baseline HF, 1,491 (28%) had hyperuricemia (serum UA ≥ 6 mg/dl for women and ≥ 7 mg/dl for men). Propensity scores for hyperuricemia were estimated using 63 baseline characteristics. Mean serum UA levels were 6.0 and 5.3 mg/dl in those with (n = 2,731) and those without (n = 2,680) hyperinsulinemia (median serum insulin ≥ 13 mU/L), respectively (p < 0.001). Propensity-adjusted hazard ratios (95% confidence intervals) for hyperuricemia-associated incident HF during 8 years of median follow-up were 0.99 (0.83 to 1.18, p = 0.886) and 1.32 (1.04 to 1.67, p = 0.021) for those with and without hyperinsulinemia respectively (p for interaction = 0.014). In conclusion, the absence of an association of hyperuricemia with incident HF in those with hyperinsulinemia (despite a significantly higher mean serum UA) and a significant association in normoinsulinemia suggest that UA has no intrinsic association with incident HF and that it may predict incident HF when it is a marker of increased of XO activity.